Attached files

file filename
10-K - 10-K - DEXCOM INCdxcm-20201231.htm
EX-32.02 - EX-32.02 - DEXCOM INCdxcm12312020exhibit3202.htm
EX-32.01 - EX-32.01 - DEXCOM INCdxcm12312020exhibit3201.htm
EX-31.02 - EX-31.02 - DEXCOM INCdxcm12312020exhibit3102.htm
EX-31.01 - EX-31.01 - DEXCOM INCdxcm12312020exhibit3101.htm
EX-21.01 - EX-21.01 - DEXCOM INCdxcm12312020exhibit2101.htm
EX-10.47 - EX-10.47 - DEXCOM INCdxcm12312020ex1047doubleda.htm
EX-10.46 - EX-10.46 - DEXCOM INCdxcm12312020exhibit1046moy.htm
EX-10.45 - EX-10.45 - DEXCOM INCdxcm12312020ex10452015espp.htm
EX-10.44 - EX-10.44 - DEXCOM INCdxcm12312020ex10442015espp.htm
EX-10.43 - EX-10.43 - DEXCOM INCdxcm12312020ex1043doindemn.htm
EX-4.04 - EX-4.04 - DEXCOM INCdxcm12312020ex404securitie.htm


Exhibit 23.01

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the following Registration Statements:

(1)Registration Statement (Form S-3 Nos. 333-206619, 333-211101 and 333-228495) of DexCom, Inc.,
(2)Registration Statement (Form S-8 No. 333-204699) pertaining to the 2015 Equity Incentive Plan and the 2015 Employee Stock Purchase Plan of DexCom, Inc., and
(3)Registration Statement (Form S-8 Nos. 333-218562 and 333-234682) pertaining to the Amended and Restated 2015 Equity Incentive Plan of DexCom, Inc.;

of our reports dated February 11, 2021, with respect to the consolidated financial statements and schedule of DexCom, Inc., and the effectiveness of internal control over financial reporting of DexCom, Inc., included in this Annual Report (Form 10-K) of DexCom, Inc. for the year ended December 31, 2020.

/s/ Ernst & Young LLP

San Diego, California
February 11, 2021